Syndromic Molecular Diagnostics for Severe Pneumonia

FDA Approved

Rapid detection of the most clinically relevant bacteria that can cause pneumonia empowers healthcare professionals to:

  • Rapidly identify pathogens and associated resistance markers
  • Optimize appropriate treatment earlier
  • Improve patient outcomes
  • Reduce healthcare costs

The Unyvero Solution

Rapid

Accurate results in hours versus 1-4 days for traditional microbiology

Comprehensive

29 targets in one test (19 bacteria and 10 resistance markers)

Simple

Sample-to-answer, easy workflow

Reliable

92.5% sensitivity, 97.4% specificity

What can Unyvero mean to you?

Microbiology Laboratories

Need to identify the pathogen and resistance quickly.

Infectious Disease

Need to know the cause to implement the right treatment plan.

Antibiotic Stewardship

Need to prescribe appropriate antibiotics for effective treatment.

Hospital Administration

Need to control healthcare costs, increase DRG yield and improve ROI.

Clinical Evidence

Recent external studies show the Unyvero LRT results are actionable:

Evaluation of A Rapid Highly Multiplexed Molecular Diagnostic Lower Respiratory Tract Panel for Clinical Impact and Antibiotic Stewardship (Beaumont Hospital)
ASM Microbe 2018

June 9, 2018

Rapid Diagnostic Testing of Bronchoalveolar Lavage to Detect Non-Fermenting Gram-Negative Bacteria and Antibiotic Resistance Genes (Northwestern University)
ATS 2018

May 16, 2018

Comparison of a Multiplex PCR Lower Respiratory Tract Assay with Bacterial Culture (UNC School of Medicine)
CVS 2018

May 07, 2018

Want to know more?